Great Medical Advances and Fearsome Costs

In November 2013, the FDA ordered a medical testing upstart named 23andMe to halt selling its $99 genetic testing service to consumers until it could prove the tests were reliable.  By February 2015, 23andMe was vindicated and able to sell at least some testing.  The FDA announced that it will allow patients to get partial […]